Status:
COMPLETED
Study of the Efficacy and Tolerance of Light Therapy in Sensitive Skin
Lead Sponsor:
University Hospital, Brest
Conditions:
Sensitive Skin
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Light-emitting diode (LED) light therapy is increasingly used successfully and without adverse effects in diabetic leg ulcer, chronic low back pain, chronic myofacial pain in the neck and in several d...
Detailed Description
The objective of the study is to evaluate the efficacy of light-emitting diode therapy in subjects with sensitive skin and to assess pain improvement, evaluation of improvement in pruritus and evaluat...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years
- Age less than or equal to 70
- Sensitive skin defined by a score ≥ 40 on the Sensiscale scale
- Patient able to consent
Exclusion
- Persons under 18 years of age or over.
- Persons suffering from disorders of higher functions preventing comprehension of the questionnaire.
- Pregnancy.
- Analgesic or medication acting on the nervous system.
- Other dermatosis of the face (example: rosacea, seborrheic dermatitis, acne ...).
- Neurological or psychiatric illness.
- A photosensitizing drug.
- Refusal of patient
- Patients under legal protection
Key Trial Info
Start Date :
June 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03279003
Start Date
June 22 2018
End Date
November 12 2018
Last Update
December 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609